FDA Approves Symbicort Asthma Combo Therapy

FDA approved AstraZeneca's asthma therapy Symbicort (budesonide/formoterol) July 21 for patients 12 and older after a standard 10-month review

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet